Prothena Corp Public (PRTA) Free Cash Flow Growth (3y) (2015 - 2026)
Prothena Corp Public (PRTA) Free Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 31.07% |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | - |
| 10 | Prothena Corp Public | 470.48 Mn | 141.02 Mn | - | 37.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.65% |
| Dec 31, 2025 | -65.67% |
| Sep 30, 2025 | -9.04% |
| Jun 30, 2025 | -9.43% |
| Mar 31, 2025 | -12.57% |
| Dec 31, 2024 | -28.04% |
| Sep 30, 2024 | -33.96% |
| Jun 30, 2024 | -24.41% |
| Mar 31, 2024 | -29.46% |
| Dec 31, 2023 | -40.05% |
| Sep 30, 2023 | 35.10% |
| Jun 30, 2023 | -34.59% |
| Mar 31, 2023 | -27.01% |
| Dec 31, 2022 | 29.44% |
| Sep 30, 2022 | -50.44% |
| Jun 30, 2022 | -42.77% |
| Mar 31, 2022 | -28.69% |
| Dec 31, 2021 | -0.28% |
| Sep 30, 2021 | 74.55% |
| Jun 30, 2021 | -14.23% |